SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 128 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,624,000 | +23.6% | 108,456 | +0.4% | 0.00% | 0.0% |
| Q1 2016 | $1,314,000 | -17.3% | 108,002 | +8.2% | 0.00% | 0.0% |
| Q4 2015 | $1,589,000 | +12.1% | 99,835 | +8.0% | 0.00% | 0.0% |
| Q3 2015 | $1,418,000 | -23.8% | 92,460 | +20.7% | 0.00% | 0.0% |
| Q2 2015 | $1,862,000 | -38.6% | 76,583 | -41.3% | 0.00% | 0.0% |
| Q1 2015 | $3,034,000 | +14.3% | 130,485 | +23.4% | 0.00% | 0.0% |
| Q4 2014 | $2,655,000 | +10.5% | 105,714 | +36.9% | 0.00% | 0.0% |
| Q3 2014 | $2,403,000 | +24.6% | 77,241 | +3.5% | 0.00% | 0.0% |
| Q2 2014 | $1,928,000 | +13671.4% | 74,593 | +12332.2% | 0.00% | – |
| Q1 2014 | $14,000 | -97.2% | 600 | -96.9% | 0.00% | – |
| Q4 2013 | $493,000 | -61.5% | 19,450 | -69.0% | 0.00% | -100.0% |
| Q3 2013 | $1,280,000 | +1142.7% | 62,744 | +1180.5% | 0.00% | – |
| Q2 2013 | $103,000 | – | 4,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
| GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
| Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
| Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
| HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
| Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
| JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
| Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |